LASCO Distributors Limited is reporting $621 million in net profit or an increase of 16 per cent for the period ended December 31, 2018.
This was largely due to increased sales across the pharmaceutical and consumer lines.
The company reflects a strong period over period consecutive revenue growth to close the period at $13.3 billion or nearly nine per cent more than the nine months ending December 31, 2017.
Total operating expenses during the nine months ended December 2018 stood at $2.1 billion, an increase of 13.6 per cent compared to the corresponding period of 2017.
Also, during the review period, LASCO Distributors increased its inventories by 0.9 per cent over the prior year to close at $2.5 billion in order to meet market demands for the products.
Total shareholders' equity was $5.2 billion, which was $718.6 million or 16.0 per cent over the prior year.